$1.355
-0.043 (-3.21%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de PACB por análisis de gráficos similares
Alphio's PACB stock price prediction model matches the current Pacific Biosciences of California Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.31 (+2.37%). The 1-week path is $1.22 (-4.36%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Pacific Biosciences of California Inc?
Pacific Biosciences (PACB) is currently not a strong buy due to its recent performance and outlook. The stock is priced at $1.40, which is below the analyst target of $1.50, indicating limited upside potential. Additionally, the company reported a significant year-to-date decline of 23.91% and has a negative forward P/E ratio of 0, reflecting uncertainty in future earnings. The recent resignation of the CEO and a downgraded revenue outlook for 2026 to $155-$165 million further complicate the investment case. The main risk lies in the company's high debt-to-equity ratio of 27223.46%, which poses a financial stability concern. Overall, while there are some positive indicators, such as a recent 5-day price increase of 3.70%, the overall sentiment and financial metrics suggest holding rather than buying at this time.
PACB cerró en $1.36 el Monday, tras bajar -3.21%
Pacific Biosciences of California Inc (PACB) last closed at $1.28, losing -5.54%. These facts feed the 1-day and 1-week PACB price prediction above.
Consenso de analistas
Pacific Biosciences of California Inc (PACB): 2 comprar, 4 mantener, 0 vender. Perspectiva: Hold.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Factores de la previsión
Los factores de la previsión de Pacific Biosciences of California Inc (PACB) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de PACB, ordenadas por similitud.
Análisis de estacionalidad de PACB
Historically the probability of a positive September return for PACB is 0.00%. January offers the highest probability of a positive month at 44.26%, while March is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de PACB
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Sep 2026 | $0.53 | $0.80 | $0.83 | -37.31% |
| Oct 2026 | $0.86 | $0.93 | $1.07 | -27.12% |
| Nov 2026 | $0.83 | $0.98 | $0.99 | -23.56% |
| Dec 2026 | $0.96 | $0.99 | $1.08 | -22.61% |
En 2026, se proyecta que Pacific Biosciences of California Inc (PACB) oscile entre $0.53 y $1.08.
Previsión mensual de Pacific Biosciences of California Inc para 2026
En Sep de 2026, se proyecta que Pacific Biosciences of California Inc promedie $0.80, con un mínimo de $0.53 y un máximo de $0.83.
En Oct de 2026, se proyecta que Pacific Biosciences of California Inc promedie $0.93, con un mínimo de $0.86 y un máximo de $1.07.
En Nov de 2026, se proyecta que Pacific Biosciences of California Inc promedie $0.98, con un mínimo de $0.83 y un máximo de $0.99.
En Dec de 2026, se proyecta que Pacific Biosciences of California Inc promedie $0.99, con un mínimo de $0.96 y un máximo de $1.08.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.